Cladridbine for the Treatment of Multiple Sclerosis
Dr. Daniel Kantor speaks with Dr. Kottil Rammohan, Professor of Neurology at University of Miami and Director of the MS Center about Cladribine for...
CMSC 2017 May 24th -27th
International Neurologists and MS Researchers will Present Opening Lectures, May 24-27Hackensack, NJ, May 8, 2017 (Newswire.com) - The preeminent conference for multiple sclerosis health...
Multiple sclerosis ”game changer” drug gets government subsidy in Australia
Melanie Row was enjoying a family holiday on the Gold Coast in 2016 when she noticed she didn't have control of her right thumb.The...
FDA Approves Siponimod (Mayzent ) for Multiple Sclerosis
The US Food and Drug Administration (FDA) has approved siponimod (Mayzent®) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include...
My MS Story: The Rules I’ve Made For Me Over The Years
I have been living with MS and a long list of autoimmune diseases for over 40 years. I have been an educator, but I...
Selma Blair Is ‘Grieving’ But ‘Still Grateful’ at First Thanksgiving Since Her MS Diagnosis
People Magazine reported today that five months after being diagnosed with multiple sclerosis, actress Selma Blair has “been grieving” her old life but is “still grateful”...
Taking My Life Back Bucket List- Episode Two
In March, I shared with you my journey of being told my prognosis was grim after 40 years of living with PPMS active, and...
Phase 2 Trial of Ibudilast Shows Slowing of Brain Shrinkage in Progressive MS
Patients living with primary progressive multiple sclerosis have eagerly been awaiting the results from phase 2 of the ibudilast study. It is the hope...
FDA OKs Second Etanercept Biosimilar for Inflammatory Diseases
FDA Approves ETICOVO™ (etanercept-ykro),
Samsung Bioepis' Second Anti-TNF Medicine in the United States
The US Food and Drug Administration (FDA) has approved a second biosimilar for...
